• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Sectors Legal & Regulations

Court ordered meeting: Shareholders approves delisting of GSK from NGX, to receive N17.42 per share   

Chris Ugwu by Chris Ugwu
December 8, 2023
in Legal & Regulations, Sectors
GlaxoSmithKline Consumer Nigeria Plc
Share on FacebookShare on TwitterShare on Linkedin

Shareholders of GlaxoSmithKline Consumer Nigeria Plc have approved the payment of N17.42 for every share held by its shareholders as part of the Scheme of Arrangement for the dissolution of the company.  

The shareholders at the Court-Ordered Meeting of GlaxoSmithKline Consumer Nigeria Plc also among other things endorsed the Daily Official List of the Nigerian Exchange Limited upon the Scheme becoming effective. 

Company Exit and Regulatory Approval

GlaxoSmithKline, the UK-based pharmaceutical giant earlier announced on August 3, 2023, that it would be leaving Nigeria and shutting down its Nigerian subsidiary, GlaxoSmithKline Consumer Nigeria Plc, subject to approval from the regulatory authorities.  

RelatedStories

GSK

GSK enters agreement to acquire IDRx for $1.15 Billion to strengthen cancer portfolio

January 13, 2025
DEAL: mPharma,Ghanaian health tech startup raises $35 million

Pharmaceutical companies can no longer cope with forex scarcity as multinationals withdraw- PMG-MAN  

July 15, 2024

According to the statement signed by the company secretary, Frederick Ichekwai, the company has received a “No Objection” from the Securities and Exchange Commission to propose a Scheme of Arrangement for its shareholders.   

Proposed Scheme of Arrangement

The proposed scheme of arrangement notes that all the company’s outstanding shares will be cancelled and all its existing shareholders except GSK UK will be settled at a premium of N17.42 for every share they hold.  

According to the company’s notice to the Nigerian Exchange Limited seen by Nairametrics, the following sub-joined resolution was proposed and duly passed as a Special Resolution:  

Resolution 

  • The Scheme of Arrangement dated November 6th 2023, a printed copy of which has been produced for the Meeting and (for purposes of identification only) signed/endorsed by the Chairman be and is hereby approved;  
  • The distributable reserves of the Company be increased by N2,000,000,000.00 (Two Billion Naira) as a result of the capital contribution by GSK of a portion of its trade debts;  
  • Other than Setfirst Limited and SmithKline Beecham Limited, who have notified the Company that they have elected not to receive their portion of the Initial Cash Distribution, and, instead, to contribute their share of it, the Shareholders of the Company be paid #17.42 (Seventeen Naira, Forty-Two Kobo) per share for every share held in the Company within ten (10) Business Days of the Effective Date (as defined in the Scheme Document);  
  • The Registrar of the Company be and is hereby authorized to include the portion of the Initial Cash Distribution that would have been payable to Setfirst Limited and SmithKline Beecham Limited to be paid to the Other Shareholders of the Company by the Scheme;  
  • That the Nigerian Exchange Limited (NGX) and Central Securities Clearing System Plc (CSCS) shall be notified and requested to terminate trading in the shares on the NGX with effect from the Eligibility Date;  
  • The shares of the Company be delisted from the Daily Official List of the Nigerian Exchange Limited upon the Scheme becoming effective;  
  • On the Capital Return Date (as defined in the Scheme Document), the Company shall return all the remaining share capital of the Company set out in the FY2023 audited financial statements to the Shareholders in exchange for the 1,195,876,488 ordinary shares of 50 Kobo each of the Company held by the Shareholders and the shares shall hereby be cancelled;  
  • Following the Capital Return Date, the share capital of the Company shall be cancelled and new shares representing #100,000.00 (One Hundred Thousand Naira), comprising 200,000 shares of 50 kobo each, shall be created and allotted to the Trustee and which shall be cancelled on the Long Stop Date (as defined in the Scheme Document) of the Scheme;  
  • The Company be re-registered as a private company from the Capital Return Date (as defined in the Scheme Document), for the sole purpose of enabling the completion of all matters about the Scheme of Arrangement before the dissolution;  
  • All Shareholders be and are entitled to receive a further Final Payment (as defined in the Scheme Document), if any, as a cash distribution in proportion to their shareholding, subject to the Company discharging all known liabilities and obligations determined as at the Long Stop Date;  
  • Under (8) above, FBNQuest Trustees Limited be authorized to carry out on behalf of the Company, all matters about the Scheme, including but not limited to the settlement of payment to creditors and any Final Payment, should any such matters be remaining outstanding and uncompleted as at the Capital Return Date;  
  • The Company shall be dissolved without being wound up no later than the Long Stop Date, being no later than the second anniversary of the Effective Date, or any other date approved by the Court; and The Board of Directors of the Company be and is hereby authorized to do all such things and take all such actions as are required to give effect to the Scheme, including consenting to any modifications of the Scheme of Arrangement or any conditions that Securities and Exchange Commission, or the Federal High Court or any other regulatory authority may think fit to approve or impose.  

 


Follow us for Breaking News and Market Intelligence.
Tags: GSK
Chris Ugwu

Chris Ugwu

Chris is a Senior Financial Analyst at Nairametrics Advocates Limited with over a decade stint in active journalism and public relations practice.

Related Posts

GSK
Health

GSK enters agreement to acquire IDRx for $1.15 Billion to strengthen cancer portfolio

January 13, 2025
DEAL: mPharma,Ghanaian health tech startup raises $35 million
Currencies

Pharmaceutical companies can no longer cope with forex scarcity as multinationals withdraw- PMG-MAN  

July 15, 2024
GSK
Company News

NGX delists GlaxoSmithKline Consumer Nigeria Plc from daily official list  

February 10, 2024
NGX, GSK
Markets

NGX suspends trading on the shares of GSK for delisting

January 27, 2024
GSK
Company News

GSK gets SEC approval for scheme of arrangement to delist from NGX

January 18, 2024
LSHTM, GSK offers scholarships to Africans for a Masters in public health in London
Career tips

LSHTM, GSK offers scholarships to Africans for a Masters in public health in London

December 17, 2023
Next Post
COP 28: UAE, several charities offer $777 million to fight tropical diseases in developing countries  

COP 28: ETI signs first sustainability-linked loan for $200 million with syndicate of European DFIs  

Comments 2

  1. Lala Benjamin Adebimpe says:
    December 8, 2023 at 6:34 pm

    Please, is there any option, in a case where a shareholder still want to retain his holding with the Company as a private entity?

    Reply
    • Sarafa says:
      December 10, 2023 at 7:56 am

      No. You do not have the option of retaining your shares in the company after the effective date as the delisted shares would also be cancelled.

      Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Emple
nlng
first bank








DUNS

Recent News

  • SEPLAT tops trading value as All-Share Index hits N80 trillion; ACCESSCORP leads volume 
  • President Trump issues 50-day ultimatum to Putin, threatens 100% tariffs over Ukraine war 
  • FG to establish National Design and Development Agency to support Nigerian innovators 

Follow us on social media:

Recent News

Weekly Stock Update: Nigerian Exchange Group record growth w-o-w, up by 0.48%

SEPLAT tops trading value as All-Share Index hits N80 trillion; ACCESSCORP leads volume 

July 14, 2025
President Trump issues 50-day ultimatum to Putin, threatens 100% tariffs over Ukraine war 

President Trump issues 50-day ultimatum to Putin, threatens 100% tariffs over Ukraine war 

July 14, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics